How to reconstitute FOXO4-DRI: mixing and storage
An experimental cell-clearing peptide with mouse findings and no established human dose.
Also called: FOXO4 DRI, FOXO4-D-retro-inverso, FOX04-DRI, Proxofim.
Senolytic peptides · Experimental FOXO4-p53 interaction-disrupting peptide · Evidence: Animal studies only.
Comes as: Powder in vials or bottles, reported by self-experimenters..
Mixed with: Bacteriostatic water is reported in forums; no approved human diluent exists..
Common vial sizes: 10 mg. Common water amounts: 1 mL.
- A 10 mg bottle appears in a Reddit report; this does not establish a standard vial size.
- One report used 1 mL for 5, 10 or 20 mg portions. These are reported mixtures, not validated recipes.
- The same report described pain and leakage. Acidic diluent was also painful.
- Water, dilution or a clear solution cannot prove sterility or remove endotoxin.
Before mixing: No validated human-product shelf life or storage range found.
After mixing: No validated stability, sterility or discard interval after mixing was found.
Related to FOXO4-DRI
- MOTS-c: A peptide the body makes; injection benefits and safety remain unproven.
- Epitalon: A peptide with telomerase effects in cells, but no proof that people live longer.
- Humanin: A peptide the body makes; injection benefits and safety remain unproven.
- Thymalin: A calf thymus extract studied for immune problems, with uncertain safety and product identity.
- Gonadorelin: A short-acting fertility hormone used in tests and specialist pump therapy.
Sources
- 21 CFR 216.23 — Bulk drug substances that can be used to compound drug products in accordance with section 503A of the Federal Food, Drug, and Cosmetic Act., Office of the Federal Register · eCFR · 2026
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, FDA · FDA · 2026
- Cellulitis, NHS · NHS · 2026
- Medicines, European Medicines Agency · European Medicines Agency · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2025
- Anaphylaxis, NHS · NHS · 2023
- Using intramuscular injections in people on oral anticoagulants, NHS Specialist Pharmacy Service · NHS Specialist Pharmacy Service · 2023
- Access an unapproved therapeutic good (health practitioners), Therapeutic Goods Administration
- Pulmonary hypertension, NHS
- Supply unlicensed medicinal products (specials), MHRA · MHRA
- Unapproved Drugs, FDA
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.